MFN Readiness Scorecard — Interactive Self-Assessment

Is Your Global Pricing Strategy MFN-Ready?

6 critical areas to evaluate before GLOBE and GUARD reshape your US reimbursement. Check each item honestly — unchecked boxes are your action items. You will receive your score, priority areas and recommended next steps once you complete the assessment.

6assessment areas 18checkpoints 5 minself-scored

Your MFN Readiness Score

0/ 18

—

What to do next

Three Priority Actions for Q2 2026

1

Model your exposure — now

Run product-level simulations of MFN impact using current reference country prices. Quantify the US revenue at risk for each product in GLOBE and GUARD therapeutic categories. This is the foundation for every other decision.
2

Audit your confidential agreements

CMS requires manufacturers to report net pricing data from all international transactions. Review every confidential rebate agreement in your reference countries for disclosure compatibility. Non-compliance creates both regulatory and financial risk.
3

Unify your pricing governance

Break down US vs. ex-US pricing silos. Establish a cross-functional framework with Market Access, Commercial and Finance aligned on a single global corridor strategy. Assign MFN strategy ownership at VP level.

Close your MFN readiness gaps — before October 2026

Our senior team will reach out within 24 hours to discuss your score and the specific gaps in your global pricing strategy.

Schedule a Strategy Discussion →

Is Your Global Pricing Strategy MFN-Ready?

Enter your details to see your score

—

Three Priority Actions for Q2 2026

Model your exposure — now

Audit your confidential agreements

Unify your pricing governance

Close your MFN readiness gaps — before October 2026